Brief: Sino Biopharmaceutical Announces Exclusive License And Cooperation Deal With YZY Biopharma
Oct 8 (Reuters) - Sino Biopharmaceutical Ltd 1177.HK :
* SIGNING OF AN EXCLUSIVE LICENSE AND COOPERATION AGREEMENT
WITH
YZY BIOPHARMA
* UNIT WILL PAY APPROXIMATELY RMB315 MILLION AS UPFRONT
PAYMENT
* UNDER DEAL, UNIT WILL PAY SALES MILESTONE PAYMENTS OF UP
TO
RMB700 MILLION TO YZY BIOPHARMA
* UNIT OBTAINED LICENSE FOR DEVELOPMENT, COMMERCIALIZATION
OF M701
DEVELOPED BY YZY BIOPHARMA IN MAINLAND CHINA
Further company coverage: 1177.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sino Biopharmaceutical
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
Brief: Sino Biopharmaceutical Says China's CDE Accepts NDA For TQH2722 Injection
Brief: Sino Biopharmaceutical China CDE Accepts New Drug Application For TQB2102 Injection
Sino Biopharmaceutical climbs on plan to raise stake in core unit